ARTICLE | Financial News
NovaQuest Capital Management LLC financial update
November 4, 2013 8:00 AM UTC
NovaQuest Capital Management closed its NovaQuest Pharma Opportunities Fund III at $459 million. NovaQuest invests in late-stage and commercial biopharmaceutical companies. The firm's active portfolio includes biosimilars company Hospira Inc. (NYSE:HSP, Lake Forest, Ill.) and pulmonary play Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY, Frenchs Forest, Australia). ...